Literature DB >> 11416725

Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin.

S Moreno1, D Podzamczer, R Blázquez, J A Iribarren, E Ferrer, J Reparaz, J M Peña, E Cabrero, L Usán.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11416725     DOI： 10.1097/00002030-200106150-00018

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers.

Authors:  D M Burger; S Agarwala; M Child; A Been-Tiktak; Y Wang; R Bertz
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  Tuberculosis and excess alcohol use in the United States, 1997-2012.

Authors:  T Volkmann; P K Moonan; R Miramontes; J E Oeltmann
Journal:  Int J Tuberc Lung Dis       Date:  2015-01       Impact factor: 2.373

4.  Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis.

Authors:  Valeria Cavalcanti Rolla; Maria A da Silva Vieira; Douglas Pereira Pinto; Maria C Lourenço; Carlos da Silva de Jesus; Mariza Gonçalves Morgado; Milton Ferreira Filho; Eduardo Werneck-Barroso
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 5.  The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review.

Authors:  Jürgen Rehm; Andriy V Samokhvalov; Manuela G Neuman; Robin Room; Charles Parry; Knut Lönnroth; Jayadeep Patra; Vladimir Poznyak; Svetlana Popova
Journal:  BMC Public Health       Date:  2009-12-05       Impact factor: 3.295

6.  Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa.

Authors:  Richard A Murphy; Holly France; Henry Sunpath; Michelle L Gordon; Vincent C Marconi; Daniel R Kuritzkes; Kenneth McIntosh
Journal:  J Trop Pediatr       Date:  2008-09-11       Impact factor: 1.165

7.  The use of anti-tuberculosis therapy for latent TB infection.

Authors:  Justin T Denholm; Emma S McBryde
Journal:  Infect Drug Resist       Date:  2010-07-21       Impact factor: 4.003

8.  AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus.

Authors:  Hadija H Semvua; Gibson S Kibiki
Journal:  BMC Res Notes       Date:  2011-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.